Navigation Links
Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV™ (acetaminophen) Injection
Date:1/18/2011

cialize OFIRMEV, and the risk that we may not be able to raise sufficient capital when needed or at all; and other risks detailed under "Risk Factors" and elsewhere in Cadence's Quarterly Report on Form 10-Q for the period ended September 30, 2010, and Cadence's other filings made with the Securities and Exchange Commission from time to time. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Cadence® and OFIRMEV are trademarks of Cadence Pharmaceuticals, Inc. Contacts:INVESTORS:

MEDIA:Cadence Pharmaceuticals, Inc.

WCGWilliam R. LaRue, SVP and Chief Financial Officer

Kelli Kampanis858-436-1400

212-301-7172blarue@cadencepharm.com

kkampanis@wcgworld.com
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV™ (acetaminophen) injection for the Management of Pain and Fever
2. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
3. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009
4. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
5. Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
6. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
7. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
9. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
11. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... 2015 The Pittcon 2015 Exposition, ... Ernest N. Morial Convention Center in New Orleans, ... February 19, 2015) displaying products and services used ... government labs. The Exposition will offer the latest ... to, analytical chemistry; drug discovery; nanotechnology; life sciences ...
(Date:2/26/2015)... Albany, NY (PRWEB) February 26, 2015 ... Market Research “Agricultural Biotechnology Market For Transgenic Crops (Corn, ... – Global Industry Analysis, Size, Share, Growth, Trends and ... valued at USD 15,300 million in 2012 and is ... at a CAGR of 9.5% from 2013 to 2019. ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... experiments indicate that infants aged 4 months or ... to detect changes in the number of objects. However, ... This week in the online journal PLoS Biology, Vronique ... evidence showing that very young infants are sensitive to ...
... Boston Scientific,Corporation (NYSE: BSX ) today announced financial results ... as well as guidance for net,sales and earnings per share ... quarter highlights:, -- Achieved adjusted EPS of $0.24 and ... both exceeding most recently issued guidance -- Grew cardiac ...
... Feb. 4 Sangamo BioSciences,Inc. (Nasdaq: SGMO ) ... provide an update on the progress of Sangamo,s ZFP,Therapeutic ... at 12:30 pm (ET) on Tuesday, February 12, 2008 ... City., The presentation will be webcast live and ...
Cached Biology Technology:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 2Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 3Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 4Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 5Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 6Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 7Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 8Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 9Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 10Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 11Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 12Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 13Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 14Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 15Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 16Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 17Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 18Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 19Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 20Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 21Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 22Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 23Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 24Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 25Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 26Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 27Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 28Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 29Sangamo BioSciences to Present at the BIO CEO & Investor Conference 2
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
(Date:1/22/2015)... MUNICH , January 22, 2015 ... its tenth year  The European Patent Office to present ... Two British nominations to be featured: Christofer Toumazou ... week featuring former finalists and winners of the Award   ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... for genetic diseases during in vitro fertilization offers couples ... genetic glitch could potentially cause doctors to misdiagnose a ... , Citing concerns about the accuracy of preimplantation ... the healthiest embryos during IVF, UF researchers set out ...
... a bid to facilitate collaboration among other biomolecular ... Laboratory has become the first institution outside the ... Consortium of Great Britain. , The BioSimGrid was ... Oxford, Southampton, Bristol, Birkbeck, Nottingham and York. Researchers ...
... lead is a well-known human health hazard, researchers at the ... of how it may work in mice to harm the ... bacteria, viruses and other bugs. , The discovery adds insight ... their emphasis from the immediate public health threat to understanding ...
Cached Biology News:Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3Grid bridges 4,800 miles for molecular repositories 2The dangerous legacy of lead 2